2015Shijie zhongxiyi jiehe zazhiRequires access

Clinical Efficacy of Tripterygium Glycosides Tablet Combined with Glucocorticoid Therapy in Patients with Nephrotic Syndrome and Analysis on Serum Inflammatory Factors

Zhang Zhi-fan

Open publisher page 1 citations

Abstract

Objective To investigate the clinical efficacy of Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome and analysis on serum inflammatory factors.Methods A total of 80 patients were randomly divided into observation group( n = 40) and control group( n= 40). Two groups of patients were given treatment on a regular basis. The control group received treatment with prednisone tablets. The observation group used Tripterygium glycosides tablets treatment except from the same therapy as the the control group. A course of treatment was eight weeks,and both groups took a total of three courses of treatment. The clinical efficacy after treatment,serum levels of inflammatory factors,urinary protein,serum albumin,total protein,serum creatinine and blood urea nitrogen levels after treatment and the adverse events were compared between the two groups. Results The total effective rate of the observation group was significantly higher,and there was a statistically significant difference( P 0. 05); after treatment,the level of IL- 1 and TNF- α in observation group were significantly lower than the same period before the treatment and control group,and there was statistically significant difference( P 0. 05); urinary protein excretion in observation group was significantly lower than the control group,while serum albumin and total protein were significantly higher than the same period before the treatment and control group,and there were statistically significant difference( P 0. 05); after treatment in terms of serum creatinine,blood urea nitrogen compared between the groups before treatment,they were significantly reduced,and a statistically significancewas found( P 0. 05); incidence of adverse reactions of the observation group was significantly lower than that of the control group,and there was a statistically significant difference( P 0. 05). Conclusion Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome has a significant clinical effect,and it can significantly reduce serum levels of inflammatory cytokines in patients with clinical significance.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome and analysis on serum inflammatory factors.Methods A total of 80 patients were randomly divided into observation group( n = 40) and control group( n= 40). Two groups of patients were given treatment on a regular basis. The control group received treatment with prednisone tablets. The observation group used Tripterygium glycosides tablets treatment except from the same therapy as the the control group. A course of treatment was eight weeks,and both groups took a total of three courses of treatment. The clinical efficacy after treatment,serum levels of inflammatory factors,urinary protein,serum albumin,total protein,serum creatinine and blood urea nitrogen levels after treatment and the adverse events were compared between the two groups. Results The total effective rate of the observation group was significantly higher,and there was a statistically significant difference( P 0. 05); after treatment,the level of IL- 1 and TNF- α in observation group were significantly lower than the same period before the treatment and control group,and there was statistically significant difference( P 0. 05); urinary protein excretion in observation group was significantly lower than the control group,while serum albumin and total protein were significantly higher than the same period before the treatment and control group,and there were statistically significant difference( P 0. 05); after treatment in terms of serum creatinine,blood urea nitrogen compared between the groups before treatment,they were significantly reduced,and a statistically significancewas found( P 0. 05); incidence of adverse reactions of the observation group was significantly lower than that of the control group,and there was a statistically significant difference( P 0. 05). Conclusion Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome has a significant clinical effect,and it can significantly reduce serum levels of inflammatory cytokines in patients with clinical significance.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome and analysis on serum inflammatory factors.Methods A total of 80 patients were randomly divided into observation group( n = 40) and control group( n= 40). Two groups of patients were given treatment on a regular basis. The control group received treatment with prednisone tablets. The observation group used Tripterygium glycosides tablets treatment except from the same therapy as the the control group. A course of treatment was eight weeks,and both groups took a total of three courses of treatment. The clinical efficacy after treatment,serum levels of inflammatory factors,urinary protein,serum albumin,total protein,serum creatinine and blood urea nitrogen levels after treatment and the adverse events were compared between the two groups. Results The total effective rate of the observation group was significantly higher,and there was a statistically significant difference( P 0. 05); after treatment,the level of IL- 1 and TNF- α in observation group were significantly lower than the same period before the treatment and control group,and there was statistically significant difference( P 0. 05); urinary protein excretion in observation group was significantly lower than the control group,while serum albumin and total protein were significantly higher than the same period before the treatment and control group,and there were statistically significant difference( P 0. 05); after treatment in terms of serum creatinine,blood urea nitrogen compared between the groups before treatment,they were significantly reduced,and a statistically significancewas found( P 0. 05); incidence of adverse reactions of the observation group was significantly lower than that of the control group,and there was a statistically significant difference( P 0. 05). Conclusion Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome has a significant clinical effect,and it can significantly reduce serum levels of inflammatory cytokines in patients with clinical significance.

Key concepts: Medicine, Tripterygium, Creatinine, Internal medicine, Prednisone, Gastroenterology, Blood urea nitrogen, Glucocorticoid

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy of Tripterygium Glycosides Tablet Combined with Glucocorticoid Therapy in Patients with Nephrotic Syndrome and Analysis on Serum Inflammatory Factors — Research Paper | ScholarLens